text: There is no conclusive evidence that thalidomide or lenalidomide is useful to bring about or maintain remission in Crohn's disease.
  Thalidomide was studied in a Phase II trial for Kaposis sarcoma, a rare soft-tissue cancer most commonly seen in the immunocompromised, that is caused by the Kaposis sarcoma-associated herpesvirus (KSHV).
  * AIDS wasting syndrome, associated diarrhea
  * Renal cell carcinoma (RCC)
  * Glioblastoma multiforme
  * Prostate cancer
  * Melanoma
  * Colorectal cancer
  * Crohn's disease 
  * Rheumatoid arthritis
  * Behcet's syndrome
  * Breast cancer
  * Head and neck cancer
  * Ovarian cancer
  * Chronic heart failure
  * Graft-versus-host disease
  * Tuberculous meningitis